StockWatch
·

GENESYS INTERNATIONAL CORPORATION LTD. Q1 FY27 Results

GENESYSQ1 FY27 Results
Filing
Result:Weak· Market: CrashedMargin squeeze
MetricValueQ4 FY26Q1 FY26
Revenue81.36 Cr21.9%14.8%
Total Income83.12 Cr22.8%15.2%
Expenditure74.80 Cr17.4%24.7%
PBT8.32 Cr51.3%31.6%
Net Profit5.28 Cr58.5%24.3%
OPM34.57%1.84pp7.06pp
NPM6.35%5.47pp3.32pp
EPS1.2658.5%28.0%
View full financials

IT/services core metric of margin quality deteriorated sharply — OPM compressed ~700bps YoY (41.63%→34.57%) and PAT fell 24.3% YoY despite 14.8% revenue growth, a clean but below-par quarter for the sector.

Q1 FY-2027 RESULTS · GENESYS

Genesys Q1 FY27: consolidated PAT -24% YoY, margins compress despite revenue +15%

PAT -24.3% YoY · revenue +14.81% · margins compressing

14 Aug 2026 · 3 min read
Revenue

₹81.36 Cr

+14.81% YoY

PAT (consolidated)

₹5.28 Cr

-24.3% YoY

Net margin

6.35%

-3.3pp YoY

EPS

₹1.26

Genesys International's consolidated revenue came in at ₹81.36 Cr, up 14.8% YoY but down 21.9% QoQ from the March quarter's ₹104.22 Cr. Consolidated PAT was ₹5.28 Cr for the period (₹5.33 Cr attributable to equity shareholders), down 24.3% YoY and 58.5% QoQ, with basic EPS of ₹1.26 versus ₹1.75 a year ago and ₹3.04 last quarter. Net profit margin compressed to 6.35% of total income from 9.67% YoY and 11.82% QoQ — the quarter is profitable but the margin trajectory is clearly down, not a loss or turnaround story.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹81.36 Cr-21.9%+14.8%
Expenses₹74.8 Cr-17.4%+24.7%
PAT₹5.28 Cr-58.5%-24.3%
Net margin6.35%-5.5pp-3.3pp
EPS₹1.26-58.6%-28%

The margin bridge is mixed by line. Operating margin (revenue from operations less project, employee and other opex, before D&A/finance costs/other income) actually widened to 34.57% from 32.73% QoQ, as the opex base fell 24.1% — faster than the 21.9% revenue drop. But that operating-line gain didn't reach the bottom line: depreciation rose to ₹18.43 Cr from ₹17.11 Cr QoQ, and other income nearly halved to ₹1.76 Cr from ₹3.45 Cr, both eating into PBT. Against the year-ago quarter, OPM compressed more directly, 41.63% to 34.57%, as the cost base grew faster than revenue. Standalone tells a sharper version of the same story: standalone PAT of ₹7.18 Cr fell 46.1% YoY (versus consolidated's -24.3%), a divergence traced to subsidiary losses narrowing to roughly ₹1.90 Cr this quarter from roughly ₹6.36 Cr a year ago — the subsidiaries were a much bigger drag in Q1 FY26, which is why the consolidated YoY decline looks comparatively milder than standalone's.

159.33215.7272.08328.45384.82181.1505-1106-0406-3007-2308-14Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹181.15, down 45.2% over the past month of trading.

₹ Cr
07.0914.1821.2819Q4 FY25rev ₹94 Cr6.98Q1 FY26rev ₹71 Cr12.05Q2 FY26rev ₹77 Cr1.05Q3 FY26rev ₹76 Cr12.72Q4 FY26rev ₹104 Cr5.28Q1 FY27rev ₹81 Cr
Quarterly consolidated PAT, ₹ Crore
Beyond the headline

What the summary numbers don't show

No exceptional items this quarter — result is clean of one-offs, unlike the ₹5.10 Cr labour-code charge absorbed in 9M/Q3 FY26

One unreviewed subsidiary posted ₹4.89 Cr revenue and a ₹2.19 Cr post-tax loss, deemed immaterial to the group by auditors

The same board meeting that approved these unaudited results also approved a leadership overhaul effective the same day: Nikhil Alulkar (previously SVP & India Country Head at Tech Mahindra, with prior stints at Microsoft and SAP) becomes CEO; long-serving CTO Aniruddha Roy moves to the newly created Chief Innovation Officer role; and Dhiman Basu Ray (ex-Tech Mahindra, TCS, Wipro, Zensar) becomes the new CTO. Separately, the company is running a ₹1,253.7 Cr rights issue (3-for-5 entitlement at ₹50/share, record date August 6, opening August 14, closing August 21) — a raise roughly 15x this quarter's revenue base, alongside prior QIP proceeds from May 2025 that remain only partially deployed as of this quarter (per note 3). No management press release accompanied this filing, the company has no formal guidance on record (db and web both blank), and a web search turned up no analyst previews or consensus estimates specific to this quarter, so both vsGuidance and vsStreet are unknown here.

  • W1

    Whether revenue recovers from the -21.9% QoQ dip next quarter or the softer ~₹81 Cr run-rate persists

  • W2

    Whether NPM rebuilds toward the 9-12% band seen over the trailing two quarters or stays compressed near 6%

  • W3

    Deployment of the ₹1,253.7 Cr rights issue proceeds (closes August 21) given prior QIP funds remain only partially utilised as of this quarter

All figures converted from ₹ Lakh; tables legible, headers unambiguous, arithmetic ties exactly. Consolidated 'profit for the period' (₹5.281 Cr) splits into ₹5.33 Cr to equity holders and ₹(0.049) Cr to NCI. No exceptional item this quarter (the ₹5.0962 Cr labour-code exceptional charge sits in 9M/Q3 FY26 and full-year FY26 only, not in Q1 FY27 or the Q1 FY26 comparator), so YoY/QoQ are clean of one-offs. One subsidiary's unreviewed interim results (revenue ₹4.892 Cr, post-tax loss ₹2.1882 Cr) are consolidated on management certification per auditor note 6, deemed immaterial to the group.

Informational and educational content only. Not investment advice.

GENESYS INTERNATIONAL CORPORATION LTD. (GENESYS) Q1 FY27 Results — StockWatch